ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MLCG ML Capital Group Inc (CE)

0.0002
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
ML Capital Group Inc (CE) USOTC:MLCG OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0002 0.00 01:00:00

ALYI Cannabis Retail Payment System Partnership With North American Cannabis Holdings Featured In Online Presentation

10/03/2017 3:25pm

InvestorsHub NewsWire


Miami, FL -- March 10, 2017 -- InvestorsHub NewsWire -- Alternet Systems, Inc. (USOTC:ALYI) today announced the latest updates to the Company’s plans to launch a cannabis retail payment system in partnership with North American Cannabis Holdings, Inc. (USOTC: USMJ) are featured in an online, on-demand presentation published by North American Cannabis Holdings and Puration (USOTC: PURA).  ALYI plans to release a dedicated online, on-demand presentation next week adding more detail to the highlights included into today’s presentation for USMJ.
 
SEE THE ONLINE ON-DEMAND PRESENTATION NOW
 
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
 
Contact: 
Henryk Dabrowski  
ir@alternetsystems.com     
+1-786-2651840 ext 7777  
 

1 Year ML Capital (CE) Chart

1 Year ML Capital (CE) Chart

1 Month ML Capital (CE) Chart

1 Month ML Capital (CE) Chart

Your Recent History

Delayed Upgrade Clock